{
    "nctId": "NCT05404321",
    "briefTitle": "Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment",
    "officialTitle": "Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment",
    "overallStatus": "RECRUITING",
    "conditions": "Triple Negative Breast Cancer, Organoid",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 163,
    "primaryOutcomeMeasure": "Rate of establishment of exploitable organoids tumor",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient over 18 years of age\n* Patient with early stage (I-III) triple negative breast cancer who needs to have clips placed before neoadjuvant chemotherapy\n* Patient affiliated to a social security system\n* Proficiency in French language,\n* Patient having signed the consent to participate in the study.\n\nExclusion Criteria:\n\n* Pregnant women\n* Persons deprived of liberty or under guardianship (including curatorship)\n* History of any other clinically active malignancy in the last 5 years prior to inclusion",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}